European Journal of Pharmaceutical Sciences, 0928-0987

Journal

  1. 2020
  2. 2019
  3. 2018
  4. Notenboom, S., Weigand, K. M., Proost, J. H., van Lipzig, M. M. H., van de Steeg, E., van den Broek, P. H. H., Greupink, R., Russel, F. G. M., & Groothuis, G. M. M. (2018). Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs. European Journal of Pharmaceutical Sciences, 115, 175-184. https://doi.org/10.1016/j.ejps.2018.01.007
  5. Yamamoto, Y., Valitalo, P. A., Wong, Y. C., Huntjens, D. R., Proost, J. H., Vermeulen, A., Krauwinkel, W., Beukers, M. W., Kokki, H., Kokki, M., Danhof, M., van Hasselt, J. G. C., & de Lange, E. C. M. (2018). Prediction of human CNS pharmacokinetics using a physiologically-based pharmacokinetic modeling approach. European Journal of Pharmaceutical Sciences, 112, 168-179. https://doi.org/10.1016/j.ejps.2017.11.011
  6. 2017
  7. 2016
  8. 2014
  9. 2013
  10. 2012
  11. Kolodkin, A., Boogerd, F. C., Plant, N., Bruggeman, F. J., Goncharuk, V., Lunshof, J., Moreno-Sanchez, R., Yilmaz, N., Bakker, B. M., Snoep, J. L., Balling, R., & Westerhoff, H. V. (2012). Emergence of the silicon human and network targeting drugs. European Journal of Pharmaceutical Sciences, 46(4), 190-197. https://doi.org/10.1016/j.ejps.2011.06.006
  12. 2010
  13. 2009
  14. 2008
  15. 2007
  16. 2006
  17. 2005
  18. Couvreur, P., Braguer, D., Crommelin, D. J. A., Duchêne, D., Engels, J. W., Kerr, D. J., Drogsgaard-Larsen, P., Meijer, D. K. F., Paoletti, R., & Wagner, E. (2005). Contribution of academic research to discovery and development of medicines: current status and future opportunities. European Journal of Pharmaceutical Sciences, 24(2-3), 245 - 252.
  19. 2004
  20. 2002
  21. 2001
  22. 2000
  23. Touw, D. J., Graafland, O., Cranendonk, A., Vermeulen, R. J., & van Weissenbruch, M. M. (2000). Clinical pharmacokinetics of phenobarbital in neonates. European Journal of Pharmaceutical Sciences, 12(2), 111-6.
  24. 1997

ID: 13206054